Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
44.05
-2.80 (-5.98%)
May 5, 2025, 4:00 PM EDT - Market closed
Guardant Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 774 | 739.02 | 563.95 | 449.54 | 373.65 | 286.73 | Upgrade
|
| Revenue Growth (YoY) | 28.20% | 31.04% | 25.45% | 20.31% | 30.31% | 33.75% | Upgrade
|
| Cost of Revenue | 299.23 | 289.8 | 227.05 | 156.33 | 122.91 | 92.54 | Upgrade
|
| Gross Profit | 474.77 | 449.22 | 336.9 | 293.21 | 250.74 | 194.2 | Upgrade
|
| Selling, General & Admin | 576.88 | 545.06 | 451.03 | 463.78 | 398.52 | 299.28 | Upgrade
|
| Research & Development | 352.47 | 347.75 | 367.19 | 373.81 | 263.22 | 149.86 | Upgrade
|
| Operating Expenses | 929.35 | 892.81 | 818.22 | 837.59 | 661.74 | 449.15 | Upgrade
|
| Operating Income | -454.58 | -443.59 | -481.33 | -544.38 | -411 | -254.95 | Upgrade
|
| Interest Expense | -2.73 | -2.58 | -2.58 | -2.58 | -2.58 | -4.77 | Upgrade
|
| Interest & Investment Income | 47.94 | 53.69 | 35.37 | 6.07 | 3.93 | 10.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.71 | 1.8 | 2.52 | -99.51 | 0.18 | 3.64 | Upgrade
|
| EBT Excluding Unusual Items | -395.66 | -390.69 | -446.02 | -640.4 | -409.47 | -245.9 | Upgrade
|
| Gain (Loss) on Sale of Investments | -19.35 | -44.4 | 50.66 | -13.05 | - | - | Upgrade
|
| Legal Settlements | - | - | -83.4 | - | - | - | Upgrade
|
| Other Unusual Items | -0.37 | - | - | - | 25 | - | Upgrade
|
| Pretax Income | -415.38 | -435.09 | -478.76 | -653.45 | -384.47 | -245.9 | Upgrade
|
| Income Tax Expense | 1.17 | 1.28 | 0.69 | 1.14 | 0.3 | 0.38 | Upgrade
|
| Earnings From Continuing Operations | -416.55 | -436.37 | -479.45 | -654.59 | -384.77 | -246.28 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -20.9 | -7.5 | Upgrade
|
| Net Income | -416.55 | -436.37 | -479.45 | -654.59 | -405.67 | -253.78 | Upgrade
|
| Net Income to Common | -416.55 | -436.37 | -479.45 | -654.59 | -405.67 | -253.78 | Upgrade
|
| Shares Outstanding (Basic) | 123 | 123 | 112 | 102 | 101 | 98 | Upgrade
|
| Shares Outstanding (Diluted) | 123 | 123 | 112 | 102 | 101 | 98 | Upgrade
|
| Shares Change (YoY) | 5.60% | 9.61% | 9.60% | 0.85% | 3.91% | 7.62% | Upgrade
|
| EPS (Basic) | -3.38 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | Upgrade
|
| EPS (Diluted) | -3.38 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | Upgrade
|
| Free Cash Flow | -304.87 | -274.94 | -345.46 | -386.92 | -284.05 | -140.1 | Upgrade
|
| Free Cash Flow Per Share | -2.47 | -2.24 | -3.08 | -3.79 | -2.80 | -1.44 | Upgrade
|
| Gross Margin | 61.34% | 60.79% | 59.74% | 65.22% | 67.11% | 67.73% | Upgrade
|
| Operating Margin | -58.73% | -60.02% | -85.35% | -121.10% | -110.00% | -88.92% | Upgrade
|
| Profit Margin | -53.82% | -59.05% | -85.02% | -145.61% | -108.57% | -88.51% | Upgrade
|
| Free Cash Flow Margin | -39.39% | -37.20% | -61.26% | -86.07% | -76.02% | -48.86% | Upgrade
|
| EBITDA | -412.67 | -401.21 | -438.44 | -508.42 | -388.73 | -238.89 | Upgrade
|
| EBITDA Margin | -53.32% | -54.29% | -77.75% | -113.10% | -104.04% | -83.31% | Upgrade
|
| D&A For EBITDA | 41.91 | 42.39 | 42.88 | 35.96 | 22.27 | 16.07 | Upgrade
|
| EBIT | -454.58 | -443.59 | -481.33 | -544.38 | -411 | -254.95 | Upgrade
|
| EBIT Margin | -58.73% | -60.02% | -85.35% | -121.10% | -110.00% | -88.92% | Upgrade
|
| Revenue as Reported | 739.02 | 739.02 | 563.95 | 449.54 | 373.65 | 286.73 | Upgrade
|
| Advertising Expenses | - | - | - | - | 2.4 | 1.2 | Upgrade
|
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.